In This Section
Back to Grantees
Loading...
AACR-PanCAN Pathway to Leadership Grant Helps Launch Scientists’ Independent Careers in Pancreatic Cancer Research

AACR-PanCAN Pathway to Leadership Grant Helps Launch Scientists’ Independent Careers in Pancreatic Cancer Research

Dedicated to accelerating the conquest of cancer, the AACR is a unique organization committed to funding research projects across all cancer sites and researchers at all career levels. In partnership with the Pancreatic Cancer Action Network (PanCAN), a nationwide organization dedicated to pancreatic cancer, the AACR-PanCAN Pathway to Leadership Grant was established in 2010. Running until 2017, the joint program offered $600,000 over five years to facilitate the career transition of pancreatic cancer researchers from postdoctoral/clinical research fellow to independent faculty.

Impact of AACR-Bayer Partnership

Impact of AACR-Bayer Partnership

The AACR and Bayer have been collaborating since 2015 to support the most promising and innovative cancer-focused research through different grant mechanisms. This partnership has yielded significant fruits, as indicated in this article.

Impact of the AACR-BCRF Partnership

Impact of the AACR-BCRF Partnership

October is breast cancer awareness month. Researchers supported by the partnership between the AACR and the Breast Cancer Research Foundation have made progress in the understanding and treatment of breast cancer on multiple fronts.

Impact of the AACR-TNBCF Partnership

Impact of the AACR-TNBCF Partnership

October is breast cancer awareness month. Researchers supported by the partnership between the AACR and the Triple-Negative Breast Cancer Foundation have made progress against triple-negative breast cancer on multiple fronts.

Collaborations for Smoking Cessation: The 2019 AACR-Johnson & Johnson Lung Cancer Innovation Science Grants

Collaborations for Smoking Cessation: The 2019 AACR-Johnson & Johnson Lung Cancer Innovation Science Grants

In recognition of the need to advance the science of lung cancer prevention and interception, the 2019 AACR-J&J Lung Cancer Innovation Science Grants program awarded grants to two multi-institutional teams whose multifaceted projects seek to understand how an individual’s genetics may affect smoking-related behaviors and quit attempts, as well as to develop clinically actionable smoking cessation strategies that will improve patient outcomes.